 |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
|
|
|
|
Stock data
| Last Trade | 5.11 | Trade Time | 5/23/2013 3:47:00 PM |
| Change |  0.06
|
Volume (thou) | 451.573 |
| %Change | 1.19% | Last Trade Size | |
| Open | 5.01 | Bid | 5.1 |
| Today's High | 5.13 | Ask | 5.11 |
| Today's Low | 4.91 | Size Bid/Ask | 36 x10 |
Fundamental Data |
|||
| Market Cap (mil) | 460830.02 | 52 Week High | 7.44 |
| Shrs Outstanding (thou) | 90182000 | 52 Week Low | 2.98 |
| EPS | -0.77 | PE Ratio | .00 |
| Volatility | Yield | .00 | |
| Dividend Freq. | 0 | Ex-Dividend Date | 12:00:00 AM |
| Dividend Amount | 0 | Exchange | NASDAQ GM |
| Delayed quotes powered by S&P comstock. All stock quotes are delayed by 20 minutes and are believed to be accurate but are not warranted or guaranteed by MENAFN.com | |||
Related News
 |
May 21, 2013 | Synergy Pharmaceuticals Presents Plecanatide Results From a Large Multicenter Clinical Study at Late-Breaking Abstract Session During Digestive Disease Week 2013, GlobeNewswire |
|
May 14, 2013 | Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index, GlobeNewswire |
|
May 13, 2013 | Semi-Annual Changes to the NASDAQ Biotechnology Index, GlobeNewswire |
|
May 09, 2013 | Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results, GlobeNewswire |
|
May 09, 2013 | Synergy Pharmaceuticals' Chief Scientific Officer to Give Plenary Lecture on Plecanatide and SP-333 at the 15th Annual TIDES Summit, GlobeNewswire |
 more... |
||
